Lockheed Martin raised full-year forecasts on strong F-35 and missile production, posting Q3 sales of $20.7 billion, up 11%, and backlog growth to a record $292 billion. The company warned, however, that spending on the Lot 20 F-35 production contract has exceeded government authorization and funding.
What's happening
- Q3 sales rose 11% to $20.7B, with net earnings up 14% to $1.8B across all four business segments.
- Backlog expanded 27% to a record $292B, driven by F-35 production and missile programs.
- Missiles and Fire Control sales increased 24%, with PAC-3 and THAAD contributing $480M and GMLRS and Precision Strike Missile adding $330M.
- Aeronautics sales grew 13%, including $710M in additional F-35 production and sustainment revenue.
- Lot 20 F-35 advance acquisition costs exceeded existing government authorization during the quarter.
Why it matters
- F-35 production constraints due to funding gaps threaten the supply rate for the world's largest defense program, affecting allied procurement and sustainment.
- Lockheed Martin's warning signals a structural mismatch between planned F-35 production and congressional appropriations, risking schedule delays and supplier capacity underutilization.
- Missile segment growth demonstrates strong demand for air defense and precision-strike weapons, but Lot 20 funding shortfall could disrupt the multi-year acquisition strategy.
Going deeper
- Rotary and Mission Systems sales grew 3% on higher radar program volume; Space sales rose 4% on Fleet Ballistic Missile and Next Generation Interceptor growth.
- Free cash flow declined to $3B from $3.3B a year earlier, attributed primarily to timing of customer receipts in the comparable 2025 quarter.
- Capital expenditure was $439M and independent R&D was $599M in Q3; company is integrating AI and autonomy into established systems through internal development and partnerships.
Financial impact
- Income statement: Q3 revenue recognition benefited from $710M in F-35 production and sustainment and $810M combined from missile programs, driving segment operating profit up $200M.
- Cash flow: Operating cash flow reflected $3B in free cash flow for Q3 2026; timing of customer receipts depressed comparison to prior year's $3.3B.
- Balance sheet: Backlog of $292B as of Q3 2026 provides forward revenue visibility; absence of authorization and funding for Lot 20 creates future cash and earnings risk.
- Dividend: Company raised dividend for the 24th consecutive year in 2026, signaling confidence in long-term cash generation despite near-term funding uncertainty.
The intrigue
- Negotiations with the U.S. government on Lot 20 and subsequent production contracts remain ongoing; without settlement, Lockheed flagged that future cash flows, operating results and financial condition would suffer, hinting at possible production slowdown or margin compression.
The fine print
- Lot 20 advance acquisition costs exceed existing authorization but negotiations continue; timing and terms of resolution undisclosed.
- Future operating results contingent on additional DoD authorization and funding for Lot 20 and subsequent F-35 production lots.




